Perspective Therapeutics (CATX) Accumulated Expenses (2011 - 2026)
Perspective Therapeutics recorded quarterly Accumulated Expenses of $3.9 million in Q1 2026, down 48.24% quarter-over-quarter from $7.5 million in Q4 2025, and up 33.1% year-over-year from $2.9 million in Q1 2025.
Perspective Therapeutics' Accumulated Expenses history runs 16 years deep, the most recent figure standing at $3.9 million for Q1 2026.
- In Q1 2026, Accumulated Expenses rose 33.1% year-over-year to $3.9 million; the TTM figure through Mar 2026 stood at $3.9 million (up 33.1% YoY), while the FY2025 annual figure was $7.5 million, up 36.71% from the prior year.
- Accumulated Expenses came in at $3.9 million for Q1 2026 at Perspective Therapeutics, down from $7.5 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $7.5 million in Q4 2025 to a low of $253000.0 in Q2 2022.
- A 5-year average of $2.8 million and a median of $2.6 million in 2024 frame the typical range for Accumulated Expenses.
- Across the five-year window, Accumulated Expenses fell 2.32% in 2022 and surged 1158.95% in 2023, its largest moves.
- Perspective Therapeutics' Accumulated Expenses stood at $285000.0 in 2022, then soared by 1158.95% to $3.6 million in 2023, then jumped by 52.68% to $5.5 million in 2024, then surged by 36.71% to $7.5 million in 2025, then plunged by 48.24% to $3.9 million in 2026.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $3.9 million, $7.5 million, and $6.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.88 Mn |
| Dec 31, 2025 | 7.49 Mn |
| Sep 30, 2025 | 6.71 Mn |
| Jun 30, 2025 | 5.04 Mn |
| Mar 31, 2025 | 2.91 Mn |
| Dec 31, 2024 | 5.48 Mn |
| Sep 30, 2024 | 3.98 Mn |
| Jun 30, 2024 | 2.31 Mn |
| Dec 31, 2023 | 3.59 Mn |
| Sep 30, 2023 | 548,000.00 |
| Jun 30, 2023 | 684,000.00 |
| Mar 31, 2023 | 764,000.00 |
| Dec 31, 2022 | 285,000.00 |
| Sep 30, 2022 | 271,000.00 |
| Jun 30, 2022 | 253,000.00 |
| Mar 31, 2022 | 256,000.00 |
| Dec 31, 2021 | 259,000.00 |
| Sep 30, 2021 | 253,000.00 |
| Jun 30, 2021 | 259,000.00 |
| Mar 31, 2021 | 240,000.00 |
| Dec 31, 2020 | 218,000.00 |
| Sep 30, 2020 | 222,000.00 |
| Jun 30, 2020 | 204,000.00 |
| Mar 31, 2020 | 183,000.00 |
| Dec 31, 2019 | 163,000.00 |
| Sep 30, 2019 | 155,000.00 |
| Jun 30, 2019 | 142,000.00 |
| Mar 31, 2019 | 134,000.00 |
| Dec 31, 2018 | 120,000.00 |
| Sep 30, 2018 | 125,000.00 |
| Jun 30, 2018 | 175,000.00 |
| Mar 31, 2018 | 140,000.00 |
| Dec 31, 2017 | 165,000.00 |
| Sep 30, 2017 | 34,000.00 |
| Jun 30, 2017 | 138,000.00 |
| Mar 31, 2017 | 25,000.00 |
| Dec 31, 2016 | 118,000.00 |
| Sep 30, 2016 | 170,000.00 |
| Jun 30, 2016 | 111,000.00 |
| Mar 31, 2016 | 119,165.00 |
| Dec 31, 2015 | 72,545.00 |
| Jun 30, 2015 | 212,795.00 |
| Jun 30, 2014 | 120,765.00 |
| Mar 31, 2014 | 117,971.00 |
| Dec 31, 2013 | 104,932.00 |
| Sep 30, 2013 | 111,276.00 |
| Jun 30, 2013 | 107,578.00 |
| Mar 31, 2013 | 100,967.00 |
| Dec 31, 2012 | 129,062.00 |
| Sep 30, 2012 | 93,322.00 |
| Jun 30, 2012 | 119,881.00 |
| Mar 31, 2012 | 82,912.00 |
| Dec 31, 2011 | 120,206.00 |
| Sep 30, 2011 | 72,668.00 |
| Jun 30, 2011 | 70,706.00 |